Charles River Laboratories International (CRL) Enterprise Value (2009 - 2026)

Charles River Laboratories International has reported Enterprise Value for 18 years, with the latest figure at $10.1 billion in Q2 2026.

• On a quarterly basis, Enterprise Value rose 40.18% year-over-year to $10.1 billion in Q2 2026; TTM through Jun 2026 was $10.1 billion, a 40.18% increase from a year earlier, with the FY2025 full-year figure at $9.9 billion, up 5.17% from the prior year.
• Enterprise Value was $10.1 billion for Q2 2026 at Charles River Laboratories International, up from $7.5 billion in the prior quarter.
• The five-year high for Enterprise Value was $14.0 billion in Q1 2022, with the low at $7.1 billion in Q3 2025.
• Average Enterprise Value over 5 years is $10.1 billion, with a median of $10.1 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Enterprise Value tumbled 59.1% in 2022, then soared 40.18% in 2026.
• Over 5 years, Enterprise Value stood at $10.9 billion in 2022, then grew by 9.23% to $11.9 billion in 2023, then fell by 21.39% to $9.4 billion in 2024, then gained by 5.17% to $9.9 billion in 2025, then grew by 3.01% to $10.1 billion in 2026.
• The last three Enterprise Value figures came in at $10.1 billion (Q2 2026), $7.5 billion (Q1 2026), and $9.9 billion (Q4 2025), per Business Quant data.